Baxter International (NYSE:BAX) Shares Break Below 50 Day Moving Average – Here’s Why

Shares of Baxter International Inc. (NYSE:BAX) crossed below its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $24.65 and traded as low as $23.37. Baxter International shares last traded at $23.4770, with a volume of 15,668,814 shares.

Key Stories Impacting Baxter International

Here are the key news stories impacting Baxter International this week:

• Positive Sentiment: Baxter reported third-quarter adjusted earnings of $0.58 per share, exceeding the $0.52 analyst consensus, while revenue increased 5% year over year to $2.98 billion and topped expectations of $2.91 billion. Growth was described as broad-based across the company’s segments. Baxter Q3 Earnings Beat on Broad-Based Growth, 2026 Outlook Raised
• Positive Sentiment: Management raised its full-year 2026 earnings outlook, signaling confidence in operating performance despite ongoing pressure on profitability. However, quarterly EPS remained below the $0.69 reported a year earlier. Baxter Raises 2026 Earnings Guidance
• Positive Sentiment: Wells Fargo raised its price target for BAX to $25 from $23, implying potential upside from recent trading levels. The firm maintained an “equal weight” rating, suggesting a constructive but cautious view. Wells Fargo Baxter Analyst Ratings
• Neutral Sentiment: Baxter declared a quarterly dividend of $0.01 per share, or $0.04 annualized. The approximately 0.2% yield provides minimal income support but maintains a cash-return program. Baxter Raises Guidance and Declares Dividend
• Negative Sentiment: The FDA issued Baxter a warning letter citing CGMP violations. The regulatory action could increase remediation costs, create operational disruptions, and raise concerns about compliance and product quality. Baxter Received FDA Warning Letter

Wall Street Analyst Weigh In

BAX has been the topic of several recent analyst reports. Citigroup reduced their target price on shares of Baxter International from $28.00 to $27.00 and set a “neutral” rating on the stock in a research note on Monday, October 5th. Jefferies Financial Group reaffirmed a “hold” rating and set a $25.00 target price on shares of Baxter International in a research report on Thursday. TD Cowen boosted their target price on shares of Baxter International from $20.00 to $24.00 and gave the company a “hold” rating in a research report on Monday, July 27th. Wall Street Zen raised shares of Baxter International from a “hold” rating to a “buy” rating in a report on Saturday. Finally, UBS Group boosted their target price on Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a report on Tuesday, July 28th. One analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, Baxter International presently has a consensus rating of “Reduce” and a consensus target price of $23.00.

Baxter International Stock Down 2.3%

The company has a market capitalization of $11.87 billion, a PE ratio of -16.28, a price-to-earnings-growth ratio of 3.54 and a beta of 0.65. The firm’s 50-day simple moving average is $24.59 and its 200 day simple moving average is $21.37. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95.

Baxter International (NYSE:BAX) last announced its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.06. Baxter International had a negative net margin of 6.23% and a positive return on equity of 16.48%. The business had revenue of $2.98 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the prior year, the firm posted $0.69 earnings per share. The company’s quarterly revenue was up 5.0% compared to the same quarter last year. As a group, equities research analysts forecast that Baxter International Inc. will post 2.05 earnings per share for the current year.

Baxter International Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, November 27th will be paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, November 27th. Baxter International’s dividend payout ratio (DPR) is currently -2.84%.

Hedge Funds Weigh In On Baxter International

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Baxter International in the second quarter valued at approximately $1,744,874,000. Pzena Investment Management LLC acquired a new position in Baxter International during the 2nd quarter worth about $1,392,098,000. Equity Investment Corp acquired a new position in shares of Baxter International in the 2nd quarter worth approximately $146,815,000. Bank of America Corp DE acquired a new position in shares of Baxter International in the 2nd quarter valued at about $132,993,000. Finally, Bank of New York Mellon Corp bought a new position in Baxter International during the second quarter worth $68,036,000. 90.19% of the stock is currently owned by hedge funds and other institutional investors.

Baxter International Company Profile

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.